Optimal use of innovative therapies for autoimmune inflammatory diseases.
Disease areas most studied are rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE).
Methodologies include investigator-initiated clinical trials, (international) registries, and studies based on direct patient contact.
Novel therapeutic strategies (e.g., treat-to-target, induction-maintenance), novel methods of doing clinical trials ('the learning healt care environment'), use of imaging in clinical care, are among the most noted recent topics of the research in my group.
ID: 100751